TEKMIRA PHARMACEUTICALS CORP — Form D

TEKMIRA PHARMACEUTICALS CORP of BURNABY, A1, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-30. The offering totals $15.0M, of which $15.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Daniel J BurgessDirectorWarminster, PA
Andrew C ChengDirectorWarminster, PA
William H CollierDirectorWarminster, PA
Richard C HenriquesDirectorWarminster, PA
Keith C ManchesterDirectorWarminster, PA
JAMES C MEYERSDirectorAustin, TX
Frank J TortiDirectorWarminster, PA
Tram C TranDirectorWarminster, PA
Eric C VenkerDirectorWarminster, PA
William H CollierExecutive OfficerWarminster, PA
David C HastingsExecutive OfficerWarminster, PA
Elizabeth C HowardExecutive OfficerWarminster, PA
Michael J McElhaughExecutive OfficerWarminster, PA
Gaston J PicchioExecutive OfficerWarminster, PA
Michael J SofiaExecutive OfficerWarminster, PA
Ian MortimerExecutive OfficerToronto, A6
Donald JewellDirectorWest Vancouver, A1
DR. MICHAEL J ABRAMSDirectorBURNABY, A1
DR. ARTHUR M BRUSKINDirectorBURNABY, A1
DR. IAN MACLACHLANExecutive OfficerBURNABY, A1
JAMES W HUDSONDirectorBURNABY, A1
DR. MARK J MURRAYExecutive OfficerBURNABY, A1
MICHAEL K FORRESTDirectorBURNABY, A1
GARY E FRASHIERDirectorBURNABY, A1
R. IAN LENNOXDirectorBURNABY, A1

Other filings by this issuer (1)

FiledFormOfferingSold
2009-03-23D

More